BIIB vs AMD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BIIB Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biogen Inc. Common Stock (BIIB) driven by superior Valuation, Momentum & Technical while AMD counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, BIIB trades at 15.6x Forward P/E with 23.5% operating margin (+10.6% YoY revenue) versus AMD at 30.2x Forward P/E and 17.8% operating margin (+44.7% YoY). In options structure, BIIB sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against AMD sits in CONSOLIDATION ($500.00 Put Wall / $600.00 Call Wall, 10th %ile IV).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | BIIB Revenue | AMD Revenue | BIIB Op. Margin | AMD Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $13.4B | $6.47B | 43.8% | 7.0% | BIIB |
| FY2019 | $14.4B | $6.73B | 49.0% | 9.4% | BIIB |
| FY2020 | $13.4B | $9.76B | 33.8% | 14.0% | BIIB |
| FY2021 | $11.0B | $16.4B | 25.9% | 22.2% | BIIB |
| FY2022 | $10.2B | $23.6B | 29.9% | 5.4% | BIIB |
| FY2023 | $9.84B | $22.7B | 11.8% | 1.8% | BIIB |
| FY2024 | $9.68B | $25.8B | 16.9% | 7.4% | BIIB |
| FY2025 | $9.89B | $34.6B | 13.1% | 10.7% | BIIB |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BIIB | AMD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $37.0B | $959.9B | Larger Scale | AMD |
| Trailing P/E Ratio Valuation | 109.9x | 125.1x | Lower Multiple | BIIB |
| Forward P/E Ratio Valuation | 15.6x | 30.2x | Lower Multiple | BIIB |
| Revenue Growth (YoY) Growth | +10.6% | +44.7% | Higher Growth | AMD |
| Operating Margin (TTM) Profitability | 23.5% | 17.8% | Higher Margin | BIIB |
| Net Profit Margin Profitability | 3.4% | 16.8% | Higher Margin | AMD |
| Return on Equity (ROE) Capital Efficiency | 1.9% | 12.0% | Higher ROE | AMD |
| 52-Week Range Position Momentum | 92% ($160โ$261) | 68% ($188โ$659) | Stronger Trend | BIIB |
| Beta / 30D Volatility Risk Regime | 0.27ฮฒ ยท 36% Vol | 3.60ฮฒ ยท 118% Vol | Lower Realized Risk | BIIB |
| Unified Institutional Score Composite Signal | 50.2 / 100 (HOLD) | 48.9 / 100 (HOLD) | Higher Composite | BIIB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BIIB vs AMD Buy Guide- Extended consolidation (103 days)
- IV expanding (+13.4%) - uncertainty/bearish
- Near put wall support ($500)